NCT02113735View on ClinicalTrials.gov

Safety and Efficacy Study of Acthar in Subjects With ARDS

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

August 31, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions

Acute Respiratory Distress Syndrome

Interventions

DRUG

H.P. Acthar® Gel (repository corticotropin injection)

DRUG

Placebo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mallinckrodt

INDUSTRY

NCT02113735 - Safety and Efficacy Study of Acthar in Subjects With ARDS | Biotech Hunter | Biotech Hunter